Even if BLA is delayed what I dont believe, we expecting Cancer results in january with more patients, which is a huge thing in itself.

Many more licensing deals in different indications or parts of the world could hit the news in the next weeks.

Or it could just continue to run on itself. Given the huge packages traded yesterday after the stock just trippled, some bigger players seems to want to get in at any price or at least as fast as possible ... .

Additionally, we are kind of protected against shortselling because we are on the OTC.

The point is, there are just to many shots on an (empty) goal in january, one at least will hit, imo.

I got a funny idea yesterday, maybe GILD is trying to hedge itself by buying our shares on the open market